Author Archive: Jeremy Parkinson
E Weekly Report: Best & Worst Sectors And Stocks – November 24, 2014
Top scoring weekly returns: Buy and Hold 1 Year Click on picture to enlarge The best scoring sector across our universe of 1,600 stocks is utilities. Consumer goods, industrial goods, and services also score above average. In the services sector, focus more on large cap and mid cap stocks than on small cap stocks. Healthcare, […]
Most Of The World Panics — Is The US Next?
It’s been quite a month. In late October Japan, despite a year of fairly aggressive quantitative easing, dropped back into recession and concluded that even easier money was the cure for its ills. It announced a debt monetization plan of almost science-fictional proportions in which the amount of new yen to be created, as a […]
Alibaba Faces “Its Most Dangerous Moment”
Alibaba Group Holding Ltd. is China’s, and probably the world’s, biggest online commerce company. Millions of users as well as businesses and suppliers use their three main sites — Taobao, Tmall and Alibaba.com. Alibaba became one of the most valuable tech companies in the world after raising $25 billion from its U.S. IPO on September […]
The Best 5 Growth Stocks
I like growth, I like momentum and I like positive investor sentiment. I wanted to find all 3 so I took a list of stocks analysts picked as high growth and ran them through Barchart to find the 5 with the most frequent new highs in the last month to get my list. The list […]
More On Germany And Nuclear
This short paper is an upgrading of a document that I published about three years ago. I am resorting to this because of the extreme amount of criticism I received for that contribution, while my present work on the nuclear future is largely overlooked by members of the anti-nuclear booster club. This is almost certainly […]
T2108 Update – Overbought For A Hot Minute With Breakout Charts Galore
(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are sometimes posted on […]
Overreaching Enthusiasm?
Bullish monetary policy rumblings from China and Europe had kick started a bright opening for markets, but the feel good factor gradually wore off as the day lengthened, and in the end, the day felt oddly bearish. The S&P closed with a bearish inverse hammer on Friday, which could turn into a bearish shooting star […]
Insider Trading Report Edition #231: Notable Buys And Sales
Welcome to edition 231 of Insider Weekends. Insider buying decreased last week with insiders buying $68.12 million of stock compared to $73.83 million in the week prior. Selling increased a little with insiders selling $1.69 billion of stock last week compared to $1.67 billion in the week prior. Sell/Buy Ratio: The insider Sell/Buy ratio is calculated by dividing the total insider […]
OMED Offers Data From Demcizumab; CELG Receives Positive CHMP Opinion For OTEZLA
OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED), a clinical-stage company developing novel therapeutics which target cancer stem cells (CSCs), or tumor-initiating cells, presented data in two posters highlighting the company’s translational research and biomarker efforts for its tarextumab (anti-Notch2/3, OMP-59R5) and demcizumab (anti-DLL4, OMP-21M18) clinical programs. These data were presented at the 26th EORTC-NCI-AACR Symposium on Molecular […]
